Receptor editing in self-reactive bone marrow B cells by unknown
Receptor  Editing  in Se•reactive  Bone  Marrow 
B  Cells 
By Susan L. Tiegs,*$ David M. Russell,* and David Nemazee*$ 
From the  *Division of Basic Sciences, Department of Pediatrics, National Jewish Center for 
Immunology and Respiratory Medicine, Denver, Colorado 80206; the tCommittee  on 
Immunology, University of Chicago, Chicago, Illinois 60637; and the SDepartment of 
Microbiology and Immunology, University of Colorado Health Sciences Center, Denver, 
Colorado 80262 
Summary 
A central paradigm of immunology is clonal selection: lymphocytes displaying donally distributed 
antigen receptors are generated and subsequently selected by antigen for growth or elimination. 
Here we show that in mice transgenic for anti-H-2K  k,b antibody genes, in which a homogeneous 
clone of developing B cells can be analyzed for the outcome of autoantigen encounter, surface 
immunoglobulin M §  + immature B cells binding to self-antigens in the bone marrow 
are induced to alter the specificity of their antigen receptors.  Transgenic bone marrow B cells 
encountering membrane-bound K b or K k proteins modify their receptors by expressing the 
V(D)J recombinase activator genes and assembling endogenously encoded immunoglobulin  light 
chain variable genes. This (auto)antigen-directed change in the specificity of newly generated 
lymphocytes is termed receptor editing. 
E 
ach B lymphocyte bears a unique antigen receptor com- 
posed of a single Ig light chain and a single heavy chain, 
despite its potential to simultaneously produce two different 
heavy chains and six different light chains (two K's and four 
)x's). This so-called "allelic exclusion" is thought to be im- 
portant in conferring on the B cell receptor a high degree 
of antigen specificity, which is critical for the process of clonal 
selection (1, 2). In adult mice, B cell production and V gene 
assembly occur in the bone marrow (3). Rearrangement and 
expression  of the Ig genes is a highly ordered process (4), 
initiated by DNA rearrangement at the heavy chain loci in 
pro-B cells, where D elements are specifically ligated to J ele- 
ments.  V.-to-DJ  rearrangement  then  ensues,  completing 
heavy chain gene assembly and leading to functional/~ heavy 
chain protein synthesis. The resulting pre-B cells then rear- 
range light chain genes, leading to their expression of surface 
IgM. Light chain rearrangement appears to occur first at the 
K  locus and, because the light chain loci have no D minigenes, 
involves only V to J rearrangement (5, 6). )x light chain V-to-J 
gene rearrangement also occurs at this stage of development, 
but cells rearranging and expressing X light chains generally 
have previously undergone nonproductive rearrangements at 
the K locus, such as KS recombination; thus, X rearrange- 
ment may represent a salvage pathway (7, 8). In developing 
B  cells,  expression  of membrane-bound /~  heavy  chains 
mediates allelic exclusion by feedback inhibition of heavy chain 
gene rearrangement (9-12). Light chain rearrangement is be- 
lieved to be blocked by the expression of membrane IgM that 
results  from the assembly of heavy and light Ig chain pro- 
teins (11, 13-15).  However,  the recent finding that circular 
DNAs excised by nested K gene rearrangements frequently 
contain rearranged VJs that are in frame and potentially func- 
tional (16) contradicts this notion and suggests that light chain 
gene rearrangement often continues in IgM + cells. 
Immature lymphocytes that have successfully recombined 
receptor genes display their antigen receptors on the cell sur- 
face where they are then selected by antigen for activation, 
inactivation, or elimination. Autoreactive lymphocytes are 
probably produced continuously in the primary lymphoid 
organs. How are such autoreactive lymphocytes controlled? 
To study negative selection of autoreactive B cells in the mouse, 
many model systems have been used. These have included 
the treatment of immature B cells from normal mice with 
tolerogens or antibodies specific for IgM (reviewed in refer- 
ence 17) and the generation of transgenic mice bearing func- 
tional, rearranged Ig genes encoding autoantibodies (reviewed 
in reference 18). These studies have yielded a wealth of infor- 
mation supporting the idea that B cells can be tolerized to 
self-antigens and suggest that more than one mechanism may 
play a role in this tolerance.  Experiments using transgenic 
mice have shown that one way that autoreactive B lympho- 
cytes are selected against in vivo is "clonal deletion" (19-25). 
In the bone marrow, encounter with cell membrane-associated 
self-antigens, capable of crosslinking Ig receptors on B cells 
with high avidity, leads to their elimination from secondary 
lymphoid tissues.  However,  a  large  pool  of self-reactive 
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that immature B cells are developmentally blocked (19, 20, 
24). In this paper we address the mechanism by which dele- 
tion occurs in B cells reactive to membrane-bound autoan- 
tigens. We test the hypothesis that receptor selection, rather 
than clonal selection, occurs in immature,  bone marrow B 
cells, and present data in support of this hypothesis indicating 
that immature autoreactive B cells encountering self-antigen 
attempt,  and  often  succeed,  in  altering  their  specificities 
through  secondary Ig light  chain  gene rearrangement. 
Materials  and Methods 
Mice and Bone Marrow Chimeras.  3-83/x/~ transgenic mice were 
produced as described (23). This transgenic mouse line bears ap- 
proximately four copies of a 42-kb heavy chain genomic construct 
containing the genomic VDJ3_s3-containing R1 fragment upstream 
of a genomic C/~-C~ construct and approximately three copies of 
an 18-kb genomic fragment containing the intact VJ3-s3-C~c light 
chain gene. The light and heavy chain transgenes cosegregate in 
breeding experiments and are probably integrated at the same locus 
(our unpublished  results).  3-83#/~  transgenic  mice were bred 
and maintained in the animal care facility at the National Jewish 
Center for Immunology and Respiratory Medicine.  MT-K  b mice 
(26) were backcrossed  twice onto a BALB/c (H-2  d) background. 
3-83/~/5 transgenic mice were bred three generations onto B10.D2/ 
oSnJ (H-2  d) and subsequently bred one generation with B10.D2/ 
oSnJ (H-2a), C57BL/10J (H-2b), B10.A/SgSnJ  (H-2KkDa), MRL/ 
MpJ-lpr (H-2k), or MT-K  b mice. The F1 mice resulting from the 
final  cross  were  analyzed.  As  the results  with  (Tg-B10.D2  x 
B10.A)F1 and (Tg-B10.D2  x  MRL/-lpr)F1 mice were indistin- 
guishable,  the results obtained with  these mice were pooled in 
Tables 1 and 2. 
Bone marrow chimeras were prepared as follows. Femurs were 
removed aseptically, ground in a mortar containing 10 ml ice-cold, 
sterile, HBSS (Gibco Laboratories,  Grand Island, NY), and filtered 
through cotton to remove bone and debris. The cells were depleted 
of erythrocytes using Gey's solution, washed twice in HBSS, and 
incubated for 30 rain on ice in HBSS containing a cocktail of anti- 
Thy-1  and  anti-CD4  antibodies.  Cells  were  then  centrifuged, 
resuspended in rabbit complement (Cedarlane,  Hornby, Canada), 
diluted to 10% in HBSS, and incubated at 37~  for 45 rain. Cells 
were then centrifuged, resuspended in HBSS, refiltered through 
cotton, washed twice in HBSS, and counted. Viable cell concen- 
tration was adjusted  to 5  x  107/ml in HBSS and 0.1 ml was in- 
jected intravenously per irradiated recipient. Aliquots of cells taken 
before and after antibody/complement treatment were analyzed for 
the presence ofT cells using immunofluorescence to determine the 
efficiency of the treatment. T cell contamination was reduced to 
<0.5%. Recipients were 4-too-old (B6.D2  x  DBA/2) (H-2  a) or 
(C57BL/6  x  DBA/2)F1  (H-2  b/a) mice  that  received  950  tad 
whole-body radiation 1 h before transfer. Mice were analyzed 3-4 
wk after transfer. 
Antibodies and Immunofluorescence.  Lymphoid cells were prepared 
as previously described (19) and stained with mAbs: anti-3-83 clono- 
type,  54.1/biotin  (19); anti-B200/FITC,  RA3-3A1  (27);  anti- 
IgM/biotin, Ak2 (28); goat anti-X/FITC (Fisher Scientific, Pitts- 
burgh, PA) was used at a dilution of 1:1,000 (similar results were 
obtained with anti-X/FITC from a different supplier [Southern Bio- 
technology Associates, Birmingham, AL]); anti-IgD  a, AMS 9.1/ 
biotin (29);  and anti-K/PE (Becton Dickinson & Co., Mountain 
View,  CA).  Biotin-conjugated  antibodies  were  revealed  with 
PE-streptavidin  (Becton Dickinson & Co.). Purification and fluoro- 
chrome conjugation of the antibodies was as described (30). Flow 
cytometry analysis was done using a Profile machine (Coulter Elec- 
tronics Inc., Hialeah, FL), and the two-color data are presented 
using its density plot function. In two-color experiments the per- 
centages of cells in each quadrant, rounded to the nearest 0.1%, 
are indicated in the upper right corner of each plot (see Fig. 4). 
Except for the cell sorting experiments, histogram analysis data 
for bone marrow cells were gated by side scatter to exclude the 
predominant myeloid cell population from analysis. 
Cell Sorting.  Bone marrow cells were stained with 54.1 antiidi- 
otype/biotin (or Ak2 anti-IgM/biotin) followed by PE-streptavidin 
in ice-cold PBS, 1% BSA, 0.1% sodium azide, washed extensively 
in the same medium,  and sorted using a EPICS 752 cell sorter 
(Coulter Electronics Inc.) equipped with a Cicero/PDP11 computer 
system (Cytomation, Ft. Collins,  CO). Sorted cells were collected 
in RPMI supplemented with 10% FCS and 0.1% sodium azide. 
Detection ofmRNA.  RNA preparation was as described  (31). 
For PCR detection of mRNA, cDNA was synthesized from total 
ILNA using a kit (Superscript;  Bethesda Research  Laboratories, 
Gaithersburg, MD) according to the instructions of the manufac- 
turer. In the cell sorting experiments, cDNA was synthesized in 
a 20-/zl reaction volume containing RNA from 106 cell equiva- 
lents. 1 ~1 of this reaction mixture was amplified with 18 cycles 
of PCR, run on 1.5% agarose gels, transferred to a Zetaprobe mem- 
brane (Bio-Rad Laboratories, Richmond, CA), and hybridized with 
probes recognizing gene transcripts of the GTP-binding protein 
G~s (32), and recombinase  activator gene (RAG)l-1 (33), RAG-2 
(34), or terminal transferase (TdT) (35). PCR reactions were done 
in a final volume of 30 ~1 containing 1/A of reverse transcription 
reaction,  10  mM  Tris-HC1  (pH  8.3),  50  mM  KC1, 1.5  mM 
MgCI~, 20 #g/ml gelatin (0.3 mM each of dATP, dCTP, dGTP, 
and dTTP, 1/~M of each oligonucleotide primer, and 1 U of Taq 
polymerase (Perkin-Elmer Corp., Norwalk, CT). Except for the 
first cycle, which had a 2-min 94~  denaturation step, each cycle 
consisted of 30 s at 94~  30 s at 62~  and 1.5 min at 72~ 
A  thermal cycler was  used  (Twinblock  TM  System;  Ericomp, San 
Diego, CA). The appropriate cloned cDNAs were used as hybrid- 
ization  probes  after labeling  with  c~-[32P]dCTP. PCR  primers 
were: RAG-l, primers F3 and R6 (36); RAG-2,  101F and 102R 
(36); G~s primers were as in Russell et al. (23); TdT, P7 (766-786), 
5'-GCTGTGTTAAATGATGAGCGA-Y;  and  P35  (1115-1134), 
5'-GTGGCTTCTGGGCTGGTAAT-3' (35).  PCR product  sizes 
were: RAG-l,  562 bp; RAG-2, 472 bp; G~s, 820 bp; TdT, 369 
bp. Control experiments showed that the dose-response of the RNA 
PCR assay is linear,  and mock cDNA synthesis  controls verified 
that the amplified material was not the result of DNA contamina- 
tion from genomic DNA or other sources. The ubiquitous G~s 
message served as an internal control for the efficiency of cDNA 
synthesis  and PCR amplification.  All of the primer pairs we used 
span  introns and thus distinguish between genomic DNA  and 
cDNA based  on the predicted sizes of the amplified  fragments. 
Excision Product  PCR Detection Assays.  PCR reactions were done 
in a final volume of 30/~1 containing 1/~1 of purified DNA solu- 
tion (at the concentration indicated) in PCR reaction buffer (10 
mM Tris-HC1 (pH 8.3), 50 mM KC1, 1.5 raM MgC12, 20 #g/ml 
gelatin 0.3 mM each of dATP, dCTP, dGTP, and dTTP, 1/~M 
of each oligonucleotide primer, and 1 U of Taq polymerase [Perkin- 
Elmer Corp.]). VJ558-to-D excision products were detected using 
the following primers:  P5 (conserved 3' of V.J558), 5'-TGAGGA- 
Abbreviations used in this paper: RAG, recombinase activator gene; TdT, 
terminal transferase. 
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Dsr~.2), 5'-TCAAAGCACAATGCCTGGCTTGGG-Y  (38). Each 
PCR cycle consisted of 30 s at 94~  30 s at 62~  and 1.5 min 
at 72~  A thermal cycler was used (Ericomp). 1/~g of input DNA 
was subjected to 27 amplification cycles under  these conditions. 
The amplified product was 563 bp long. Vxl-to-Jx~ excision prod- 
ucts were detected using the following primers: P46 (3' of Vxl), 
5'-GCTGCATACATCACAGATGC-Y;  P47  (5'  of Jxl),  5'-CAA- 
TGATTCTATGTTGTGCC-Y  (39).  DQs2-to-J. excision products 
were  detected  using  the  following  primers:  P25  (3'  of DQS2), 
5'-AAGACCTGTCCACAGTAACTCG-3'; P24 (5' ofJ,), 5'-ATA- 
GGAACAGAGGCAGAACAGA-  Y  (40). 
For  PCR  amplification of Vxt-to-Jxt  and  DQs2-to-J,  excision 
products each cycle consisted of 60 s at 94~  2 min at 64~  and 
2 min at 72~  0.1 #g of input DNA was subjected to 27 ampli- 
fication cycles under these conditions. The amplified products are 
290  bp  for  Vxl-to-J~a excision product  and  182,  502,  883,  and 
1,451  bp for DQs2-to-J,1.2.3.4, respectively. PCR products were run 
on 1.5% agarose gels and transferred onto zeta probe membranes 
(Bio-Rad Laboratories) in 0.4 N  NaOH.  The appropriate cDNA 
or PCR products were used as hybridization probes after labeling 
with ot-[32p]dCTP using the hexamer labeling method (41). Filters 
were hybridized with probes for 16 h  at 68~  in 0.5 M  NaPO4 
(pH 7.2),  1 mM EDTA, 7%  SDS.  Filters were washed to a final 
stringency of 0.1x  SSC (15  mM NaC1,  1.5 mM sodium citrate 
[pH 7.4]), 0.1%  SDS at 65~  and then exposed to X-ray film. 
Linear dose-response of the excision product assays was verified by 
including different input amounts of normal mouse bone marrow 
DNA in the assays and measuring the amounts of PCR product de- 
tected in Southern blotting by 32p radioactivity quantitation using 
a  Phosphorlmager  (Molecular Dynamics,  Inc., Sunnyvale,  CA). 
Results 
Membrane Autoantigens Expressed on Peripheral Cells or on 
Cells throughout the Whole Body Delete Autoreactive B Cells.  To 
analyze the mechanism of B call tolerance we produced trans- 
genic mice bearing  functional,  rearranged  heavy  and  light 
chain genes encoding the H-2K k,b antibody specificity 3-83 
(19, 23).  In this study we used the 3-83~/8  transgenic line, 
which  encodes  3-83  Ig of the  IgM  and IgD  isotypes (23). 
3-83~/8  mice that were H-2  d (nondeleting mice) were vir- 
tually monodonal with respect to B cells, with >95% bearing 
the 3-83 idiotype (23).  In contrast,  when membrane  K k or 
K b autoantigen  was  present  on  the  whole  body  (centrally 
deleting mice) most B  cells, including virtually all idiotype- 
positive B ceils, were deleted from the spleen and lymph nodes 
(Table  1),  but were present  in the bone marrow  (Table 2). 
Cell surface immunofluorescence  staining with mAb  to the 
pan B  cell marker B220 confirmed that autoreactive B  cells 
were  deleted from  the peripheral lymphoid  organs  and  re- 
tained in the bone marrow (compare Tables 1 and 2). A  similar 
profound deletion of autospecific B cells in the lymph nodes, 
and to a lesser extent in the spleen, was observed in 3-83~/8 
mice bred with  MT-K  b transgenic  mice (26),  in which  the 
Table  1.  Increased Number of A  Light Chain-bearing B  Cells in Centrally Deleting, but Not in Pe@herally Deleting, Transgenic Mice 
Lymph  nodes  Spleens 
Mouse  type (n)  B220  X  K  id  B220  ~  K  id 
Unmanipulated mice" 
H-2  d Tg (9) 
(nondeleting 
H-2  d Tg X MT-K  b (7) 
(peripherally  deleting) 
H-2  d Tg X H-2  b (7) 
(centrally deleting) 
H-2  d Tg X H-2  k (4) 
(centrally deleting) 
Non-Tg (7) (normal) 
Bone marrow chimeras~ 
H-2  d Tg--~H-2  d (3) 
(nondeleting) 
H-2 Tg--*H-2  b/d (4) 
(centrally deleting) 
Non-Tg---~H-2  b/d (3) 
(normal) 
Non-Tg-'~H-2  a (3) 
%  % 
24.4 _+ 5.7  0.08  .+ 0.05  24.6  -+ 5.8  24.4  +  5.7  44.4  _+ 6.5  0.3  .+ 0.2  47.8  .+ 6.5  45.8  .+ 6.4 
0.9  _+ 0.8  0.07  ,+ 0.07  0.6 .+ 0.3  0  9.6  ,+ 4.3  0.5  ,+ 0.6  8.6 .+ 4.9  7.3  ,+ 3.1 
1.5 ,+ 0.8  0.6  .+ 0.6  1.0 _+ 0.5  0  6.4  -+ 4.3  2.6  _+ 2.2  3.1  +  1.6  0.7  _+  1.1 
3.7 .+  1.8  1.1  ,+ 0.4  2.4  ,+  1.4  0  13.5  -+ 6.7  4.9  _+ 2.2  9.1  ,+ 4.8  0.2  -+ 0.3 
29.0  _+ 5.9  1.0 .+ 0.33  29.1  ,+ 6.7  0  51.5  -+ 7.6  2.3  .+ 0.8  53.4  _+ 7.7  0 
58.9  _  10.8  0.13  .+ 0.05  53.1  _+ 15.4  50.7  ,+  16.4  52.1  _+  16.7  0.2  ,+ 0.1  51.5  .+  19.7  48.4  ,+  16.4 
4.4 _+ 1.5  1.0  .+ 0.20  3.4 _+ 1.2  0.1  .+ 0.2  11.6 ,+ 4.0  2.9  _+ 1.4  9.0 .+  1.2  0.3 _+ 0.3 
51.9  .+  1.6  3.5  _+ 0.5  52.3  .+ 5.2  0  57.7  ,+ 8.9  4.1  ,+ 0.8  57.4 .+ 4.2  0 
67.7  .+ 3.4  4.5  .+ 0.6  64.4  + 0.7  0  67.7  + 3.4  4.4 .+ 0.4  73.2  _+ 7.7  0 
* Mean  _+  SD from four to six experiments. Mice were 2 mo.  old. 
* Mean from three experiments. Mice were analyzed 21-26 d  after transfer in three independent experiments. 
1011  Tiegs et al. Figure  1.  Elevated  expression of RAG-1 and RAG-2, but not TdT, in the bone marrow  of centrally deleting  mice detected using a PCR assay. 
(A) cDNA synthesized from the bone marrow RNA of an 8-wk-old B10.D2 nontransgenic littermate  mouse was subjected to various numbers of 
PCR amplification cycles as described in Materials and Methods using pairs of oligonucleotide primers specific for RAG-2 and the ubiquitous GTP- 
binding protein, Gas. Synthesized fragments were detected by Southern blotting, and the amount of probe hybridized was quantitated.  Based on these 
results 18 cycles of amplification using the conditions described in Materials and Methods were chosen for the subsequent quantitation experiments. 
(B and C) Various amounts of cDNA synthesized from  the bone marrow RNA were subjected to 18 cycles of the PCR with primers specific for 
RAG-2 and Gas. (B) Autoradiogram  of Southern  blot used to detect specific amplification of RAG-2 and Gas. (C) Measurement  of radioactivity 
in the visualized bands of B. Dilution of input cDNA: lane a, undiluted; lane b, 1:5, lane c,  1:10; lane d,  1:25. The RAG-2 cpm/Gas cpm ratios 
were very similar at all cDNA dilutions tested: 0.52,  0.53, 0.47, 0.56 for a-d,  respectively. (D) Comparison of recombinase message levels in bone 
marrow RNA of individual transgenic and nontransgenic  mice. PCR detection of RAG-l, RAG-2, and TdT mRNA in bone marrow cells was performed 
as described in Materials and Methods. Shown are autoradiograms of Southern blots used to detect PCR products.  (Left) Samples were from 5-wk-old 
mice;  (right) samples were from  8-wk-old mice. 
Table  2.  Increased Abundance  of Bone Marrow RAG  mRNA  and B  Cells in  Centrally  Deleting,  but Not  in Pe@herally  Deleting, 
Transgenic Mice 
Mouse  type  RAG-2 mRNA*  (n)  %  B220+-cells  ~ (n)  %  Ig+-cells  * (n) 
H-2  d Tg  (non deleting)  1.0  +  0.38  (5)  11.7  _+  1.9  (5)  9.7  _+  1.4  (5) 
H-2  a Tg  x  MT-K  b (peripherally deleting)  1.2  _+  0.38  (4)  13.3  _+  5.9  (4)  10.6  _+  4.7  (4) 
H-2  d Tg  x  H-2  b (centrally deleting)  3.4  _+  0.75  (4)  19.1  _+  4.9  (3)  16.0  +_  5.7  (3) 
H-2  d Tg  x  H-2  k (centrally deleting)  8.3  _+  2.1  (2)  15.2  +  0.9  (3)  11.7  +_  0.7s (3) 
Non-Tg (normal)  11.6  _+  6.5  (6)  23.8  _+  6.9  (3)  6.4  _+  2.0  (3) 
* PCR detection of RAG-2 mRNA was performed as described in Materials and Methods using detection of Gas mRNA as internal control. Relative 
abundance was calculated as: (cpm RAG-2 probe hybridized/cpm Gas probe hybridized)~,p~  .....  i/(cpm RAG-2 probe hybridized/cpm Gas probe 
hybridized)m,~n  of nondd~tin~  s,mples. Data shown are expressed as mean relative abundance.  All mice were  2 mo old. 
Percent  of total viable bone marrow cells. 
S As  the slg + cells in this group had a very low level of staining, this value is only approximate. 
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hepatocytes,  exocrine  pancreatic  cells,  and  kidney  tubules 
(peripherally deleting mice) (Table 1) (see also reference 23). 
As shown below, comparison  of the peripherally  and cen- 
trally deleting mice provided insights  into  the mechanism 
of deletion. 
Elevated RAG  Expression in Bone Marrow IgM + Cells of 
Centrally Deleting Mice.  To examine the possibility that sec- 
ondary Ig gene rearrangements  are induced upon encounter 
of B cells with tolerogen, we measured RAG-1 and RAG-2 
(33, 34) expression in bone marrow cells using a quantitative 
PCR assay (Fig.  1).  Nondeleting,  H-2  d 3-83#/~ mice have 
greatly reduced levels  of both  RAG-1  and  RAG-2 relative 
to nontransgenic littermates, presumably because of the feed- 
back regulation that maintains  allelic  exclusion (15) (Fig.  1 
D, lanes Ig-Tg, and Table 2). Peripherally deleting mice showed 
similar  low levels  of RAG-1  and  RAG-2  (Fig.  1 D,  lanes 
Ig-Tg/H-2K b  periphery, and Table 2).  In striking contrast, and 
consistent with the possibility that  secondary Ig gene rear- 
rangements are induced in B cells by interaction with auto- 
antigen, centrally deleting mice had greatly increased RAG-1 
and  RAG-2 levels  that  approached  the levels  in  nontrans- 
genic mice (Fig.  1 D, lanes Ig-Tg/H-2 b and Ig-Tg/H-2 k, and 
Table 2). 
To determine which cells in the bone marrow of centrally 
deleting mice were responsible for the elevated RAG expres- 
sion, we separated idiotype-positive and idiotype-negative cells 
and measured their RAG-1 and RAG-2 levels. For these ex- 
periments we chose to analyze centrally deleting mice bearing 
the antigen K b, which is a low affinity ligand for the 3-83 
antibody, because the level of idiotype detected on the sur- 
face of bone marrow  B220 + cells is  higher  in  these mice 
than  in  H-2  k  centrally  deleting  mice  and  thus  allows  a 
cleaner  cell separation.  Fig.  2 A  shows that  the  idiotype- 
positive cells were highly enriched for RAG-2 expression and 
accounted for most of the bone marrow  RAG-2 message, 
as demonstrated by the depletion of RAG-2 in the idiotype- 
negative cells. The lack of RAG expression in the idiotype- 
Figure 2.  Most  RAG-2 mRNA from H-2  b centrally deleting bone marrow is contained in stgM  + cells. (A) 3-83 idiotype-positive  cells  were stained 
with the anticlonotype antibody  54.1/biotin, followed  by PE-avidin, and sorted as described  in Materials and Methods. RNA was isolated from sorted 
and nonsorted populations and PCR detection was carried out as in Fig. 1. (Bottom) Autoradiogram of Southern blot used to detect PCR products. 
(RT,  +/- ) Addition or omission of reverse transcription during the cDNA synthesis procedure  before  PCtL amplification. (B) A similar analysis as 
in A for bone marrow cells from a normal, nontransgenic mouse sorted on the basis of slgM expression. (C) RAG-2 expression analysis of sorted 
nondeleting, peripherally deleting, and centrally deleting mouse  bone marrow cells. In this experiment Gots probe of lower specific  activity was used 
to better reveal the RAG-2 signal. 
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cells, because in normal mouse bone marrow cells that were 
sorted similarly using anti-IgM antibodies most, but not all, 
of the RAG-2  mRNA  was  present  in  the  slgM-  popula- 
tion (Fig. 2 B). The idiotype-positive cells of the nondeleting 
and peripherally deleting transgenic mice were also enriched 
in RAG-2 mRNA, but this message was present at a lower 
level than in the idiotype-positive cells isolated from centrally 
deleting mouse bone marrow (Fig. 2 C). These results reflect 
the relative amounts of RAG-2 message seen in the total mouse 
bone marrow RNA preparations (Table 2). The significance 
of the residual RAG expression in the slg + cells of the non- 
deleting and peripherally deleting mice is unclear,  as these 
cells demonstrate little functional Ig gene rearrangement (see 
below). Because binding by the antiidiotypic antibody is de- 
pendent  on coexpression of the transgenic light  and  heavy 
chains, these experiments demonstrate that bone marrow B 
cells bearing intact  surface (s)IgM  can express RAG-1  and 
RAG-2, and that the levels of RAG mRNAs  are highest in 
cells that have bound (auto)antigen in the bone marrow. In- 
terestingly, centrally deleting mice bearing the high affinity 
ligand K k expressed more RAG-1 and RAG-2 in their bone 
marrow,  but  had no more bone marrow  B  cells  than  cen- 
trally deleting  mice expressing  the  low  affinity ligand  K b 
(Table 1). This suggests that the affinity of the antigen-receptor 
interaction affects the probability that a bone marrow IgM + 
cell will express recombinase. 
Elevated  Light Chain Gene Recombination  in Centrally  Deleting 
Bone Marrow Cells.  To test whether or not the elevated RAG 
expression in centrally deleting bone marrow cells reflected 
Figure 3.  PCR detection of Ig 
gene rearrangement excision  prod- 
ucts. (A) General strategy for the 
PCR detection  of Ig gene  rearrange- 
ment excision  products. Filled and 
open rectangles represent Ig gene 
coding segments. Open and filled 
triangles represent rearrangement 
signal sequences  with 12- and 23-bp 
spacers, ~spectively.  Primers  a and b 
are  oligonucleotides that  initiate 
DNA synthesis on opposite DNA 
strands in the indicated directions. 
(B) Amplification  of VxvtoJxl exci- 
sion product from purified  normal, 
nontransgenic  mouse  bone marrow 
DNA. Effect  of altering the number 
of PCR cycles on the amount of 
amplified product. Based on these 
results 27 cycles of amplifications 
using the conditions described in 
Materials and Methods was chosen 
for the subsequent quantitation ex- 
periments. (C)  Dose-response of 
input normal bone marrow DNA 
amount  on  Vxl-to-J￿  excision 
product  signal detected after  27 
cycles  of  amplification.  Similar 
linear dose-response curves were 
seen in experiments detecting the 
other types  of  excision  product (not 
shown).  (D-G)  Detection  of Ig 
gene rearrangement excision  prod- 
ucts in bone marrow DNA. Bone 
marrow DNA from 8-wk-old mice 
was analyzed for excision  products 
of: (D and G) Vxl-to-J￿  joining 
(D, comparison of a number of in- 
dividual 2-mo-old  mice; G, compar- 
ison of one mouse of each group 
using different starting amounts of 
bone marrow DNA); (E) V.J558- 
to-D joining;  (F) Dqs2-to-J~  join- 
ing. PCP, products were visualized 
by Southern blotting  followed by 
autoradiography. 
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Ig gene rearrangement  excision products in bone marrow 
DNA using a PCR assay (Fig. 3). This assay takes advantage 
of the fact that during recombination the heptamer-nonamer 
signal sequences flanking the two joined Ig gene coding ele- 
ments are themselves ligated, and the resulting structure can 
be detected and amplified using PCR with appropriately de- 
signed oligonucleotide primers (shown schematically in Fig. 
3 A).  The strength of this approach,  at least for V.-to-D, 
DQ52-to-J.,  and Vh-to-J)' rearrangements, is that these ex- 
cision products, unlike the corresponding coding products 
that are retained by the chromosome, are always deleted from 
the chromosome and so their quantity should not be affected 
by the possible subsequent growth of the cells. In addition, 
because each cell has a limited number of loci that can rear- 
range, the amount of excision product detected is likely to 
reflect the fraction of cells undergoing gene rearrangement. 
These experiments showed that the level of )'1 light chain 
excision products in bone marrow DNA preparations were 
extremely high in centrally deleting but  not  peripherally 
deleting or nondeleting mice (Fig. 3, D  and G). Thus, au- 
toantigen expression in the bone marrow is correlated with 
increased Ig gene recombination activity. Similar results were 
obtained with )'2-specific  assays (not shown). By contrast, 
V.-to-D  excision  products  were  not  elevated  in  bone 
marrow cells of centrally deleting mice, indicating that light 
chain, but not heavy chain, rearrangement is induced in the 
centrally deleting mice (Fig. 3 E). 
Interestingly, increased levels of Dqsz-to-J~  excision prod- 
ucts  were detected in  the bone marrow  cells of centrally 
deleting mice, relative to the levels seen in the bone marrow 
cells of nondeleting and peripherally deleting control mice 
(Fig.  3 F).  The appearance in centrally deleting B cells of 
D,-to-J. joining, but not V.-to-D joining, is similar to the 
IgH rearrangement patterns seen in T cell lines (42) and prob- 
ably reflects a less restrictive control of the accessibility of 
the elements needed for D.-to-J. joining compared with the 
control of the accessibility of elements needed for V.-to-D 
rearrangements. 
Bone marrow DNA preparations also were analyzed for 
Vg-to-Jt~  rearrangements by the excision product assay. As 
for the )' loci tested, the bone marrow cells of centrally deleting 
mice had greatly elevated levels of detectable excision prod- 
ucts, relative to the bone marrow cells of peripherally deleting 
or nondeleting transgenic mice (data not shown). These results 
support the idea that r  light chain genes are also induced 
to rearrange in centrally deleting mice. However, these data 
are more difficult to interpret for K than for the other loci 
tested, because in K, in contrast to the other Ig loci, many 
Vs rearrange by inversion. In the case of inversion the signal 
joints that our assay recognizes are retained on the chromo- 
some upstream of the CK, and their quantity is therefore poten- 
tially subject to subsequent cellular selection. 
Elevated A  Light  Chain Expression in  Centrally Deleting 
Mice.  In deleting transgenic mice small numbers of B cells 
that lack the autoreactive specificity escape deletion and ap- 
pear  in  the peripheral  lymphoid organs.  A  large  fraction 
(•1/3)  of the B cells found in centrally deleting mouse lymph 
nodes expressed ), light chains (Table 1). These ), chains must 
have been the result of rearrangement and expression of en- 
dogenous )' loci because the transgenic light chain is g. Lymph 
node cells of centrally deleting mice had ~10-fold more )'+ 
cells than lymph node cells of peripherally deleting and of 
nondeleting mice, both in terms of the absolute numbers of 
)'+ cells and in terms of the percentage of total lymph node 
cells.  This  high  frequency  of  )'+  cells  in  the  centrally 
deleting mice was not a simple result of selective outgrowth 
of idiotype-negative cells, because peripherally deleting mice, 
which had even more profoundly depressed lymph node B 
cell levels, had as few )`-bearing lymph node cells as the non- 
deleting 3-83/x/6 mice. Although the peripherally deleting 
mice had nearly twofold more )`-bearing cells in the spleen 
than the nondeleting mice (0.5 vs. 0.3%), this increase was 
relatively slight compared with the 8-16-fold increase seen 
in the spleens of centrally deleting mice (Table 1). We note 
that the slight increase in the percentages of B220 + cells in 
the lymph nodes of centrally deleting mice, relative to that 
percentage in peripherally deleting mice, can be largely ac- 
counted for by the increase in the fraction of )`-bearing cells. 
These data document the increased rearrangement of endog- 
enous light chain genes in the B cells of centrally deleting 
mice at  the level of light chain protein expression. 
To more directly examine the potential of bone marrow 
B cell precursors developing in deleting or nondeleting en- 
vironments to give rise to )`-bearing cells, we constructed 
radiation chimeras. Aliquots of bone marrow cells from non- 
deleting,  H-2 a  3-83  #/t~  mice  were  used  to  reconstitute 
lethally irradiated H-2 a or H-2 a/b recipients.  3-4 wk after 
transfer the mice were analyzed.  Again,  centrally deleting 
mice demonstrated a greatly increased frequency of )'-bearing 
cells, while the nondeleting transgenic chimeras demonstrated 
excellent light chain isotype exclusion (Table 1). These cells 
were of donor origin because double staining of peripheral 
B cells with anti-I-A  b and anti-B220 antibodies revealed that 
>95% of the B cells in all samples were donor derived and 
virtually all detectable bone marrow B cells in the deleting 
chimeras had low levels of 3-83 idiotype (not shown). Since 
the transgenic donor bone marrow was H-2 a,  this experi- 
ment also shows that for the induction of 5, + B cell produc- 
tion in these chimeras the B cell receptor had to emerge onto 
the cell surface and receive an antigenic signal from another 
cell. This result is important because pre-B cells and B cells 
express class I MHC molecules and might have conceivably 
required autoantigen expression internally, for example in the 
endoplasmic reticulum, to induce ), production. It also sug- 
gests that any antigen that is present in the bone marrow, 
and is capable of crosslinking B cell receptors with sufficient 
avidity, can induce recombinase expression and secondary light 
chain rearrangement  in slgM + cells. 
In Centrally Deleting Mice A Chain-bearing B  Cells Arise 
from Self-reactive B Cells.  To determine whether or not )' + 
B cells from centrally deleting mice arose from autoreactive 
precursors, we analyzed bone marrow cells by two-color im- 
munofluorescence with antiidiotype and anti-), antibodies (Fig. 
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Figure 4.  Detection of  idio- 
type  +/~,* B ceils in the bone mar- 
row of a centrally  deleting  mouse. 
Idiotype  was detected  with the 3-83 
donotytx'-specific rat mAb 54.1, 
which recogniz~  an epitopr  created 
by the pairing of 3-83 heavy and 
fight chains, h-bearing ceils were 
visualized with a goat anti-mouse 
X/FITC conjugate.  The binding  of 
biotin conjugated  54.1 was revealed 
with  PE-streptavidin. For  each 
sample 100,000 events were ana- 
lyzed.  Data  were  dectroni~lly  gated 
based on 90  ~  light  scatter  to exclude 
from analysis  the predominant  my- 
doid cell population. 
4). A small, but significant population of double-positive cells 
could be dearly identified. Roughly half of the X-positive 
ceils expressed idiotype (id). Double-positive id+/X + cells 
do not appear in the peripheral lymphoid organs of centrally 
deleting mice; thus, in the bone marrows of centrally deleting 
mice, the predicted  id+/X + intermediate  in the receptor 
editing process  could be detected. In addition, in the periphery 
of centrally deleting mice essentially all h + B cells coexpress 
the transgenic  heavy chain,  as  shown by two-color im- 
munofluorescence  analysis  with antibodies specific  for X chains 
and for IgD heavy chains (/~ chains) of the transgenic allo- 
type (Fig. 5). Because virtually all B cells in the centrally 
deleting mice bear Ig heavy chains of the transgenic allotype, 
these cells must retain and express the heavy chain transgene. 
These results indicate that the peripheral X-expressing  B ceils 
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Figure 5.  Peripheral  X  light  chain-bearing  B cells  in a centrally  deleting 
mouse coexpress the transgenic heavy  chain. Spleen ceils from an 8-wk- 
old 3-83#/~ transgenic  mouse  bred to the C57BL/10  background  (Ig heavy 
chain allotype  b, H-2K~) were stained  with anti-h/FITC  and anti-IgD=/ 
biotin. On this genetic background the anti-lgD  ~  antibody  only  reacts 
with transgene-encoded  IgD. The binding of the biotin conjugate  was 
revealed with PE-streptavldin. 
in centrally deleting mice coexpress  transgenic heavy chain 
genes and they support the V.-to-D excision product data, 
suggesting that receptor editing involves assembly of light 
chain, but not heavy chain, V  genes (Fig.  3). 
Discussion 
Although Ig receptor generation and antigenic selection 
in B cells have been generally thought to be independent 
processes, we find that in immature, IgM + bone marrow B 
lymphocytes these  processes  are  intimately linked.  Bone 
marrow B ceils expressing receptors  that are crosslinked by 
autoantigen express high levels of recombinase gene mKNAs 
and continue to rearrange Ig light chains. Evidence for rear- 
rangement activity in bone marrow cells of centrally deleting 
mice came from experiments demonstrating: (a) devated levels 
of tLAG-1 and tLAG-2 mRNA in bone marrow cells of cen- 
trally deleting mice; (b) elevated expression  of these recom- 
binase  genes  in  slgM +  bone  marrow  cells  of centrally 
deleting mice; (c) devated levels of light chain rearrangement 
excision products in bone marrow cells of centrally deleting 
mice; and (d) expression of endogenously encoded light chain 
protein in cells expressing transgenic Ig in bone marrow cells 
of centrally deleting mice. These results suggest that autoreac- 
tive bone marrow B cells are often rescued from elimination 
by an induced alteration of the structure and specificity of 
their antigen receptors. While our results in a sense reinforce 
the concept of clonal selection,  as cells with autoreactive 
specificities do indeed disappear  in our system, the receptor 
editing idea represents an important conceptual departure from 
the prevailing dogma of clonal selection, which holds that 
selection against self-reactive clones requires their functional 
or physical elimination. In essence, the distinction between 
donal selection and receptor editing is that in receptor editing 
the fates of the autoreactive B cell and its receptor are un- 
coupled. 
The Case against Feedback  Regulation.  The elevated expres- 
sion of RAG-1 and RAG-2 accompanied by increased X light 
chain gene rearrangement in the bone marrow of centrally 
1016  Receptor  Editing in Self-reactive  Bone Marrow B Cells deleting mice raises  the question of feedback in hematopoi- 
esis.  It could be argued that  a paucity of B cells in the pe- 
riphery  or in the bone marrow induces elevated RAG ex- 
pression in bone marrow cells of centrally deleting mice as 
a consequence of an overall increase in B cell production. We 
think this is unlikely for several reasons: (a) the peripherally 
deleting mice, which are highly B cell deficient, fail to dem- 
onstrate RAG upregulation (Fig.  1); (b) the cells that are en- 
riched  for  RAG  expression  in  bone  marrow  of centrally 
deleting mice are not pre-B cells,  as would be predicted by 
a feedback model, but slgM + cells  (Fig.  2);  (c) expression 
of terminal  transferase,  a pro-B stage-specific gene,  is not 
elevated in bone marrow cells of centrally deleting mice (Fig. 
2);  (d) rearrangement  in bone marrow B cells of centrally 
deleting mice occurs at the light chain loci, but not detect- 
ably at the heavy chain loci (Fig. 3); (e) in mixed bone marrow 
chimeras, in which an excess of normal, nontransgenic B cells 
of all developmental stages develops alongside a minority popu- 
lation of transgenic B cells, the autoreactive transgenic B cells 
continue to demonstrate elevated k light chain rearrangement 
(data not shown);  (f) a simple feedback model cannot ex- 
plain the different X/K ratios in peripherally deleting and cen- 
trally deleting mice; and (g) studies on anti-IgM-suppressed 
mice,  SCID mice,  and SCID mice bearing active Ig trans- 
genes indicate that depletion of mature and immature B cells, 
late-pre-B cells, or late pro-B cells does not increase the rate 
of formation, or steady-state levels, of their precursors in the 
bone marrow  (3,  43,  44). 
The Receptor  Editing Hypothesis.  Based on these results we 
have formulated the following model for the role of Ig gene 
rearrangement  in B cell tolerance (Fig. 6). Cells at the pre-B 
to B cell transitional stage of development in the bone marrow 
are undergoing K rearrangement.  The appearance of IgM on 
the cell surface normally turns off further recombination. We 
propose  that  if the  newly emerging  or  recently  emerged 
receptors are autoreactive, and their surface IgM is erosslinked 
by membrane-bound autoantigen, the following sequence of 
events takes place.  (a) Recombinase levels in the autoreactive 
B cells are high,  either because expression fails to be shut 
down or because the recombinase machinery is newly ex- 
pressed.  (b) Because recombinase is now expressed in a cell 
with  recombinase-accessible light  chain  V  genes,  but  not 
recombinase-accessible heavy chain V genes, secondary rear- 
rangement occurs in the K locus. (c) If light chain rearrange- 
ment is successful, the previously active K VJ is rendered in- 
active by nested rearrangement and deletion, or by inversion, 
which places the VJ far away from CK. Rearrangement con- 
tinues until a new, functional VJ is generated,  or until the 
CK loci are inactivated by using up the available J/s or by 
RS recombination.  The functional light chain must fail to 
result in an autoreactive receptor or the editing process will 
be resumed, starting at step a. It is also possible at this stage 
that a new light chain that pairs preferentially with the cell's 
/~ chain can in some cases extinguish the B cell's anti-self- 
specificity without eliminating the active, autospecific VJ on 
the other chromosome. This has been clearly shown by Gay 
et al. (45) in their anti-DNA transgenic mouse system. Their 
funct/ona/kappa 
rearrangement 
IgM  cell 
t 
Figure 6.  A model for receptor editing. Pre-B cells that have function- 
ally rearranged light chain genes display surface IgM that can bind an- 
tigen. Absence  of strong slgM crosslinking by antigen allows the B cell 
to mature. (1) Strongly  crosslinking antigen induces light chain rearrange- 
ment and altered antigenic specificity  in immature B cells. (2) Cells that 
fail to alter their antiself specificity  or that lack receptors may eventually 
die in situ. 
work also underscores the importance of editing in eliminating 
potentially pathogenic specificities.  (d) Those cells that have 
activated  RS  recombination,  which  deletes  the  CK locus, 
now make ), loci available for rearrangement and expression. 
In the mouse, further editing of active X light chain loci that 
encode autoantibodies is not generally possible, given the or- 
ganization  of the ~, genes;  however, in other species,  such 
as humans,  nested secondary V~Jx rearrangements  that can 
eliminate  active VxJx's may be possible. 
The Importance of  Secondary Ig Gene Rearrangements.  Sec- 
ondary Ig gene rearrangements are defined as rearrangements 
caused by the V(D)J recombinase system in loci that  have 
already undergone V  region  gene assembly.  In the case of 
nonfunctional rearrangements,  such as out-of-frame coding 
joints, secondary (and higher order) rearrangements can allow 
multiple attempts at generating functional Ig genes. Mouse 
Ig gene organization has a number of interesting features that 
may be important in limiting, or facilitating, such secondary 
rearrangements.  The heavy chain V, D, and J minigenes are 
in the same transcriptional  orientation (46). Thus, VDJ recom- 
bination deletes the intervening DNA between the active V. 
and D. segments and that between the rearranged  D. and 
J. segments.  This results in the loss of all other D's from 
that  allele  of the Ig locus and eliminates  the possibility of 
further rearrangements using conventional signal sequences. 
By contrast, the K locus has V genes in different orientations 
relative to the J's, and thus can rearrange by deletion or in- 
version of the intervening DNA (47-49).  Because in the K 
locus the V's recombine directly to J's,  and there are four 
functional JK's, nested rearrangement is possible. Furthermore, 
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inversional VK-JK rearrangement, the entire repertoire of VK's 
is available for secondary rearrangements. That such secondary 
rearrangements can occur in ~ has been well documented 
(48-50). In addition, because VK rearrangements to JK1 and 
JK2 are most frequent (51), downstream J's are often avail- 
able for secondary rearrangements in the K loci. By contrast, 
loci each have a single J and, like the heavy chain V genes, 
rearrange by a deletional mechanism (52, 53).  Thus, in the 
mouse, Ig gene organization appears  to uniquely favor sec- 
ondary rearrangements in K. 
Secondary Rearrangement of lg Genes in B Cells Can Alter 
Specificity.  How can the concept of receptor editing be recon- 
ciled with the observation of allelic exclusion? There are a 
number of well-documented reports of secondary Ig gene 
rearrangements in murine B cell tumor lines already expressing 
intact IgM on the cell surface (54-56). These rearrangements 
can create new, functional light or heavy chain genes, effec- 
tively changing the antigen specificity of the cells in the pro- 
cess. Two groups demonstrated a novel form of recombina- 
tion at the IgH locus, called V gene replacement, in which 
coding sequences of the rearranged, functional V gene are 
replaced by upstream germline V  gene segments (54,  57). 
This V.-to-V.DJ. recombination appears to be mediated by 
cleavage and recombination in a highly conserved heptamer 
in the 3' portion of the rearranged V. coding sequence. This 
heptamer is identical to, and in the same orientation as, that 
found 5' of D  elements, suggesting that in V. to V.DJ. 
replacement, the same enzymatic machinery that mediates 
the familiar V,-to-DJ. recombination is involved.  It has not 
been determined whether or not this process occurs in normal 
cells.  Nevertheless, we cannot exclude a role for V. gene 
replacement in receptor editing. Evidence for a functional 
secondary rearrangement at the light chain locus has been 
provided by Levy et al. (55):  independent idiotype variants 
of the  surface IgM §  tumor  38C13  were  shown  to  have 
deleted  and  replaced  the  rearranged,  functional  V~JK2 by 
recombination between upstream VZs and downstream JK's. 
This type of nested rearrangement has been observed frequently 
in myelomas and hybridomas in situations where the rear- 
rangement was inversional (48-50).  In normal B cells, cir- 
cular DNAs excised by nested K gene rearrangements have 
been demonstrated. Interestingly, these circles frequently con- 
tain rearranged VJs, about one-third of which are in-frame 
and potentially functional (16). Finally, in the NFS-5 tumor, 
under conditions in which it expresses  surface IgM (/~,K), 
light chain rearrangement may occur. The )~ protein product 
competes efficiently for binding to heavy chain with the func- 
tional K protein, extinguishing surface K expression (56).  In 
all the above examples, not only do the rearrangements create 
a new specificity, but they extinguish the original specificity 
of the B cells. Secondary rearrangements have been thought 
to occur in developing B cells that fail to make functional 
Ig receptors; the data presented in this paper suggest that 
autoreactive B cells can similarly be rescued and made nonau- 
toreactive by secondary Ig gene rearrangement. 
Our model may help to explain exceptions to the para- 
digm of feedback inhibition of Ig gene rearrangement. For 
example, Storb and her colleagues (58, 59) have observed that 
in K chain transgenic mice, in which feedback inhibition of 
K rearrangement is effective in most B cells,  a subset of B 
cells appears to ignore the expressed transgene and continues 
to rearrange endogenous K and X light chains.  We predict 
that in this subset of B cells the transgenic light chain paired 
with the cell's #  heavy chain confers autoreactive specificity 
that is sufficient to activate the receptor editing process. 
Antigen Receptor Selection in the Primary Lymphoid Organs. 
Recent work on T lymphocyte selection suggests that thymic- 
positive selection or TCR crosslinking can terminate ongoing 
TCK c~ chain gene rearrangement in immature TCR + T 
cells (60,  61), providing another example of a link between 
antigen receptor crosslinking in immature lymphocytes and 
V(D)J recombinase regulation.  Our results demonstrating 
secondary light chain rearrangement in immature B cells en- 
countering autoantigen in the bone marrow differ substan- 
tially from the results with T cells, however, because we find 
that receptor crosslinking in immature B cells turns recom- 
binase on,  rather  than  off.  However,  slgM + lymphomas 
generated in El~-N-myc transgenic mice downregulate RAG 
expression upon slg crosslinking (62).  It is possible  that B 
cells are uniquely adapted to use the receptor editing mecha- 
nism for the elimination of potentially harmful autoreactive 
B cells, whereas T  cells make use of receptor editing to in- 
crease their chances of being positively selected. We assume 
that the receptor editing we detect in transgenic mice reflects 
a process occurring in normal cells as suggested by the pres- 
ence of a  subset  of slgM+/RAG +  cells  in  normal bone 
marrow (62)  and the abundance of in-frame VKJK joins in 
circular excised B cell DNA from normal mice (16). In both 
B and T lymphocytes receptor editing could relieve develop- 
mental "bottlenecks" in which large numbers of cells are 
selected against, by providing a means of rapidly generating 
cells with appropriate specificities at an early developmental 
stage through the sequential alteration and testing of their 
antigen receptors. 
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